论文部分内容阅读
目的观察阿奇霉素联合布地奈德混悬液雾化吸入治疗小儿支原体肺炎的临床效果。方法将96例支原体肺炎患儿随机分为观察组和对照组各48例,观察组给予阿奇霉素联合布地奈德混悬液治疗,对照组给予阿奇霉素联合盐酸氨溴索治疗,观察2组患儿的临床效果、症状缓解时间及不良反应。结果观察组总有效率为93.75%高于对照组的70.83%,差异有统计学意义(P<0.05)。观察组发热消除、喘憋缓解、啰音消失、咳嗽缓解时间均短于对照组,差异均有统计学意义(P<0.05)。观察组不良反应发生率明显低于对照组,差异有统计学意义(P<0.05)。结论阿奇霉素联合布地奈德混悬液雾化吸入治疗小儿支原体肺炎效果显著,可改善临床症状,提高患儿身体状况,值得临床推广应用。
Objective To observe the clinical effect of azithromycin combined with budesonide suspension atomization inhalation in the treatment of mycoplasma pneumonia in children. Methods 96 cases of children with mycoplasma pneumonia were randomly divided into observation group and control group, 48 cases in each group. The observation group was given azithromycin combined with budesonide suspension. The control group was given azithromycin combined with ambroxol hydrochloride. Clinical effect, symptom relief time and adverse reaction. Results The total effective rate in the observation group was 93.75% higher than that in the control group (70.83%), the difference was statistically significant (P <0.05). The observation group, fever, asthma relief, rales disappeared, cough relief time shorter than the control group, the difference was statistically significant (P <0.05). The incidence of adverse reactions in the observation group was significantly lower than that in the control group, the difference was statistically significant (P <0.05). Conclusion Azithromycin combined with budesonide suspension atomization inhalation treatment of children with mycoplasma pneumonia significant effect can improve clinical symptoms and improve the physical condition of children worthy of clinical promotion and application.